Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Mental Health

Date Submitted: Jan 23, 2024
Date Accepted: Jan 31, 2024

The final, peer-reviewed published version of this preprint can be found here:

Efficacy of BrighterSide, a Self-Guided App for Suicidal Ideation: Randomized Controlled Trial

Josifovski N, Torok M, Batterham P, Wong Q, Beames J, Theobald A, Holland S, Huckvale K, Riley J, Cockayne N, Christensen H, Larsen M

Efficacy of BrighterSide, a Self-Guided App for Suicidal Ideation: Randomized Controlled Trial

JMIR Ment Health 2024;11:e55528

DOI: 10.2196/55528

PMID: 38551212

PMCID: 11004607

BrighterSide: A randomised controlled trial of a self-guided app for suicidal ideation

  • Natasha Josifovski; 
  • Michelle Torok; 
  • Philip Batterham; 
  • Quincy Wong; 
  • Joanne Beames; 
  • Adam Theobald; 
  • Sarah Holland; 
  • Kit Huckvale; 
  • Jo Riley; 
  • Nicole Cockayne; 
  • Helen Christensen; 
  • Mark Larsen

ABSTRACT

Background:

Self-guided digital interventions can reduce the severity of suicidal ideation, although there remain relatively few, rigorously evaluated, smartphone apps targeting suicidality.

Objective:

This trial evaluated whether the BrighterSide® smartphone app intervention was superior to a waitlist control group at reducing the severity of suicidal ideation.

Methods:

550 adults aged 18-65 with recent suicidal ideation were recruited from the Australian community. In this randomized controlled trial, participants were randomly assigned to receive either the BrighterSide® intervention app, or to a waitlist control group which involved treatment as usual. The app was self-guided, and participants could use the app at their own pace for the duration of the study period. Self-report measures were collected at baseline, 6-weeks, and 12-weeks. The primary outcome was severity and frequency of suicidal ideation, and secondary outcomes included psychological distress and functioning and recovery. Additional data were collected on app engagement and participant feedback.

Results:

Suicidal ideation reduced over time for all participants, but there was no significant interaction between group and time. Similar improvements were observed for self-harm, functioning and recovery, days out of role, and coping. Psychological distress was significantly lower in the intervention group at the 6-week follow-up, but this was not maintained at 12 weeks.

Conclusions:

The BrighterSide® app did not lead to a significant improvement in suicidal ideation, relative to a waitlist control group. Possible reasons for this null finding are discussed. Clinical Trial: Australian New Zealand Clinical Trials Registry (ACTRN12621000712808).


 Citation

Please cite as:

Josifovski N, Torok M, Batterham P, Wong Q, Beames J, Theobald A, Holland S, Huckvale K, Riley J, Cockayne N, Christensen H, Larsen M

Efficacy of BrighterSide, a Self-Guided App for Suicidal Ideation: Randomized Controlled Trial

JMIR Ment Health 2024;11:e55528

DOI: 10.2196/55528

PMID: 38551212

PMCID: 11004607

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.